Thyme Care, a cancer care company, has raised $95 million in Series C funding to expand its business of supporting cancer patients in 31 states. The company offers care navigation services, technology, and therapeutic interventions to help patients understand their diagnosis, find doctors, and receive clinical care between appointments. The funding includes equity from various investors and debt financing from Banc of California. Thyme Care aims to improve patient outcomes and reduce costs in cancer care. With the funding, the company plans to scale its business through new services and partnerships with risk-bearing entities. The ultimate goal is to help more cancer patients nationwide.
Source link
Thyme Care Raises $95M To Advance Cancer Care
